X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (54) 54
gastroenterology & hepatology (31) 31
index medicus (30) 30
male (26) 26
female (25) 25
adult (24) 24
crohn's disease (19) 19
middle aged (18) 18
inflammatory bowel disease (16) 16
crohns-disease (14) 14
inflammatory-bowel-disease (14) 14
infliximab (14) 14
antibodies, monoclonal - therapeutic use (13) 13
ulcerative colitis (13) 13
adolescent (12) 12
treatment outcome (12) 12
animals (11) 11
research (10) 10
risk factors (10) 10
ulcerative-colitis (10) 10
aged (9) 9
crohn disease - drug therapy (9) 9
medical research (9) 9
mice (9) 9
abridged index medicus (8) 8
prospective studies (8) 8
young adult (8) 8
analysis (7) 7
gastroenterology and hepatology (7) 7
inflammation (7) 7
inflammatory bowel diseases - drug therapy (7) 7
severity of illness index (7) 7
biopsy (6) 6
crohn disease - immunology (6) 6
drug therapy, combination (6) 6
gastrointestinal agents - therapeutic use (6) 6
genomes (6) 6
immunology (6) 6
immunosuppressive agents - therapeutic use (6) 6
infusions, intravenous (6) 6
medicine (6) 6
pediatrics (6) 6
time factors (6) 6
anti-inflammatory agents - therapeutic use (5) 5
child (5) 5
colitis, ulcerative - drug therapy (5) 5
colorectal cancer (5) 5
crohn disease - genetics (5) 5
crohn disease - pathology (5) 5
crohn disease - surgery (5) 5
dendritic cells (5) 5
development and progression (5) 5
disease models, animal (5) 5
gastroenterology (5) 5
genetics (5) 5
inflammatory bowel diseases (5) 5
inflammatory bowel diseases - genetics (5) 5
nutrition & dietetics (5) 5
phosphorylation (5) 5
recurrence (5) 5
research article (5) 5
rodents (5) 5
surveys and questionnaires (5) 5
t-cells (5) 5
therapy (5) 5
aged, 80 and over (4) 4
antibodies, monoclonal - administration & dosage (4) 4
antibodies, monoclonal, humanized (4) 4
azathioprine - therapeutic use (4) 4
biology (4) 4
colitis (4) 4
crohn disease (4) 4
cytokines (4) 4
dose-response relationship, drug (4) 4
double-blind method (4) 4
drug therapy (4) 4
follow-up studies (4) 4
genetic aspects (4) 4
genetics & heredity (4) 4
health aspects (4) 4
intestinal mucosa - immunology (4) 4
intestinal mucosa - pathology (4) 4
laparoscopy (4) 4
lymphocytes (4) 4
medical and health sciences (4) 4
medicin och hälsovetenskap (4) 4
medicine, experimental (4) 4
meta-analysis (4) 4
monoclonal-antibody ca2 (4) 4
mutation (4) 4
netherlands (4) 4
prevention (4) 4
quality of life (4) 4
quality-of-life (4) 4
rheumatoid-arthritis (4) 4
studies (4) 4
surgery (4) 4
tumor necrosis factor-alpha - antagonists & inhibitors (4) 4
tumor necrosis factor-alpha - immunology (4) 4
1506 (3) 3
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The American Journal of Gastroenterology, ISSN 0002-9270, 02/2011, Volume 106, Issue 2, pp. 199 - 212
Journal Article
Gut, ISSN 0017-5749, 08/2013, Volume 62, Issue 8, pp. 1122 - 1130
Objective Etrolizumab (rhuMAb β7, anti-β7, PRO145223) is a humanised monoclonal antibody targeting the β7 subunit of the heterodimeric integrins α4β7 and αEβ7,... 
IBD basic research | IBD clinical | Etrolizumab | apoptosis | IBD | MONOCLONAL-ANTIBODY | antibody targeted therapy | HUMANIZED ANTIBODY | CELL-ADHESION MOLECULE-1 | integrins | dendritic cells | genetics | safety | rhuMAb 7 | pharmacokinetics | inflammatory bowel disorders | LAMINA PROPRIA LYMPHOCYTES | ulcerative colitis | cytokines | immunology | T-CELLS | EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS | CROHNS-DISEASE | cell cycle | signal transduction | IBD models | drug development | Crohn's disease | E-CADHERIN | IBD-genetics | autoimmune disease | INFLAMMATORY-BOWEL-DISEASE | arthritis | CD103(+) DENDRITIC CELLS | GASTROENTEROLOGY & HEPATOLOGY | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Gastrointestinal Agents - administration & dosage | Antibodies, Monoclonal - therapeutic use | Male | Antibodies, Monoclonal - blood | Dose-Response Relationship, Drug | Young Adult | Antibodies, Monoclonal, Humanized | Injections, Subcutaneous | Adult | Female | Colitis, Ulcerative - drug therapy | Severity of Illness Index | Double-Blind Method | Treatment Outcome | Colitis, Ulcerative - blood | Antibodies, Monoclonal - administration & dosage | Adolescent | Gastrointestinal Agents - therapeutic use | Aged | Gastrointestinal Agents - adverse effects | Gastrointestinal Agents - blood | Infusions, Intravenous | Headache | Immunoglobulins | Intravenous administration | Wound healing | Dendritic cells | Migration | Inflammation | Injection | Retention | Crohns disease | Cell adhesion & migration | Inflammatory bowel disease | Studies | Lymphocytes | Monoclonal antibodies | Remission | Pharmacokinetics | Chronic illnesses | Ulcerative colitis | Integrins | Index Medicus | Abridged Index Medicus | rhuMAb β7 | Inflammatory Bowel Disease | IBD–genetics | 1506
Journal Article
Nature genetics, ISSN 1061-4036, 2010, Volume 42, Issue 4, pp. 332 - 337
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 2011, Volume 6, Issue 8, p. e23745
Journal Article
Gut, ISSN 0017-5749, 02/2012, Volume 61, Issue 2, pp. 241 - 247
Journal Article
Journal Article
BMC Cancer, ISSN 1471-2407, 03/2009, Volume 9, Issue 1, pp. 88 - 88
Background: Tumor cell death generates products that can be measured in the circulation of cancer patients. CK18-Asp396 (M30 antigen) is a caspase-degraded... 
ASSAY | CYTOKERATIN-18 | ONCOLOGY | PRO-APOPTOTIC DRUGS | CARCINOMAS | BAX | SERUM | M30 | HYPOXIA | Colorectal Neoplasms - surgery | Multivariate Analysis |